MBCL-43. RECURRENT MEDULLOBLASTOMA – LONG-TERM SURVIVAL WITH A “MEMMAT” BASED ANTIANGIOGENIC APPROACH

INTRODUCTION: Patients with recurrent medulloblastoma have a poor prognosis with only around 8% of patients surviving at 5 years irrespective of salvage therapy used. We report on 29 patients from four institutions treated with a “MEMMAT” based antiangiogenic combination therapy. PATIENTS AND METHOD...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Slavc, Irene, Peyrl, Andreas, Gojo, Johannes, Holm, Stefan, Blomgren, Klas, Sehested, Astrid M, Leblond, Pierre, Czech, Thomas
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Medulloblastoma (Clinical)
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715695/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.516
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki